Skip to content

Cocoa Flavanols and Exercise Capacity

The Impact of Dietary Cocoa Flavanols on Cardio-pulmonary Exercise Capacity in Human.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01259739
Enrollment
13
Registered
2010-12-14
Start date
2010-11-30
Completion date
2013-11-30
Last updated
2013-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise Capacity

Keywords

trained cyclists, no medications, no diseases, non-smokers

Brief summary

The purpose of this study is to characterize the potential improvement of cocoa flavanols on exercise capacity in highly trained cyclist. A placebo-controlled double-blinded randomized control study will be performed in 13 highly trained cyclist (crossover design). Participants will perform a baseline exercise testing on an ergometer. They will receive either a flavanol-poor or flavanol rich cocoa drink twice daily for one week before a second and third exercise testing is performed. The order of drinks is randomized and balanced (high-flavanol--\>low-flavanol drink or low-flavanol drink--\>high-flavanol drink)

Detailed description

13 participants (highly-trained cyclist, accustomed to exercise testing on ergometers will be enrolled (VO2max\>50 ml/kg, FMD \>5%, non-smokers, no medication, no diseases, age 20-36, male). Baseline Testing: Participants will perform a baseline testing consisting of an ergometric test with a step-wise increase of workload until exhaustion to determine lactate anaerobic threshold and cardio-pulmonary exercise capacity. Vascular function is monitored by Doppler Ultrasound. In a second test, participants will perform a time trial (goal: as fast as possible) Flavanol intervention Participants will twice daily receive either a flavanol-poor cocoa drink (13mg/dl)or a flavanol-rich cocoa drink (596mg/dl) over a period of 7 days. Order is randomized and balanced. Subjects will crossover to the second arm after a washout period of 7 days. Testing performed on baseline day is repeated after the intake of both drinks In a subgroup of n=6 participants, we will test whether the blood pressure cuff maneuver used for FMD will itself modify nitrite levels. For this the manuever will be completed 4 times and compared to n=6 untreated controls. in another subgroup 6 participants will receive 4times the maneuver but reperfusion will be limited by means of an ultrasound probe.

Interventions

OTHERCocoa

dissolved in water twice-daily intervention

Sponsors

Heinrich-Heine University, Duesseldorf
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
20 Years to 36 Years
Healthy volunteers
Yes

Inclusion criteria

* highly trained cyclists (VO2 peak \> 50 ml/kg bodyweight) * refrain from cocoa ingestion during trial * training continued throughout testing * \> 20 years * male

Exclusion criteria

* \> 36 years * poor endothelial function * acute infection * any chronic heart or pulmonary disease * arrhythmias * acute or chronic renal failure * smokers * cardio-vascular risk factors : diabetes mellitus, hypertension, hyperlipidemia * intake of nutrition supplements (l-arginine, creatinine) * intake of WADA listed doping substances

Design outcomes

Primary

MeasureTime frame
Cardiopulmonary exercise capacity (time to complete time trail, lactate anaerobic threshold, cardio-pulmonary exercise capacity7 days

Secondary

MeasureTime frame
Endothelial function7 days

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026